A research programme by the Access to Medicine Foundation

There are 74 results for 'Overall ranking'

The Access to Medicine Index finds that a handful of pharmaceutical companies are developing the bulk of urgently needed new medicines for the poor

Amsterdam, the Netherlands, 20 November 2018 – The development of new medical products that are considered the highest priority for people in developi...

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.